All patients | CV- | CV+ | |||||
All | Responders | Nonresponders | All | Nonresponders | Responders | ||
Subjects | 80 | 51 | 36 | 15 | 29 | 24 | 5 |
Demographics | |||||||
Age yrs | 63±9 | 63±10 | 63±9 | 62±10 | 63±9 | 62±9 | 70±5 |
Male | 39 (49) | 26 (51) | 18 (50) | 8 (53) | 13 (45) | 8 (33) | 5 (100) |
BMI kg·m−2 | 24.1±3.3 | 24.1±3.2 | 24.3±2.6 | 23.5±4.4 | 24.0±3.4 | 23.4±3.3 | 26.9±2.5 |
History of TLVR | 7 (7) | 5 (9) | 3 (8) | 2 (13) | 2 (7) | 0 | 2 (40) |
Smoking status n | |||||||
Former smoker | 77 | 48 | 34 | 14 | 29 | 24 | 5 |
Current smoker | 2 | 2 | 2 | 0 | 0 | 0 | 0 |
Never-smoker | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
Lung function | |||||||
FEV1 % pred | 32±10 | 32±10 | 33±10 | 31±10 | 32±10 | 31±10 | 38±9 |
DL,CO % pred | 37± 15 | 37±16 | 39±17 | 32±12 | 37±14 | 37±15 | 36±13 |
RV % pred | 239±62 | 237±53 | 237±50 | 237±61 | 242±76 | 255±76 | 181±43 |
TLC % pred | 134±21 | 133±18 | 134±18 | 131±19 | 135±25 | 139±24 | 119±22 |
RV/TLC | 0.66±0.1 | 0.66±0.1 | 0.66±0.09 | 0.65±0.1 | 0.67±0.11 | 0.68±0.11 | 0.62±0.13 |
Patient outcomes | |||||||
6MWT# m | 317±111 | 327±117 | 324±108 | 335±140 | 298±97 | 299±102 | 291±84 |
SGRQ¶ points | 63±12 | 63±12 | 64±12 | 60±11 | 63±13 | 58±16 | 64±13 |
Emphysema characteristics | |||||||
α1-antitrypsin deficiency | 3 (3) | 3 (5) | 2 (6) | 1 (7) | 0 | 0 | 0 |
Heterogeneity | |||||||
Heterogeneity score | 19±14 | 20±15 | 22±15 | 16±16 | 18±12 | 18±14 | 16±6 |
≤15% (nonheterogeneous) | 36 (44) | 20 (39) | 14 (39) | 6 (40) | 16 (55) | 12 (50) | 4 (80) |
Not determined | 4 (5) | 3 (6) | 2 (6) | 1 (6) | 1 (3) | 1 (4) | 0 |
Target lobe | |||||||
Right upper | 35 (44) | 15 (29) | 8 (22) | 7 (47) | 20 (69) | 18 (75) | 2 (40) |
Right middle | 2 (3) | 2 (4) | 1 (3) | 1 (7) | 0 | 0 | 0 |
Right middle and right lower | 1 (1) | 1 (2) | 0 | 1 (7) | 0 | 0 | 0 |
Right lower | 8 (10) | 7 (14) | 5 (14) | 2 (13) | 1 (4) | 0 | 1 (20) |
Left upper | 17 (21) | 12 (24) | 10 (28) | 2 (13) | 5 (17) | 5 (21) | 0 |
Left lower | 17 (21) | 14 (27) | 12 (33) | 2 (13) | 3 (10) | 1 (4) | 2 (40) |
History of lung transplant, LVRS or BVR | 7 (9) | 5 (10) | 2 (6) | 3 (20) | 2 (7) | 2 (8) | 0 |
Bullae | 5 (6) | 3 (6) | 2 (6) | 1 (7) | 2 (7) | 1 (4) | 1 (20) |
Data are presented as mean±sd or n (%), unless otherwise stated. CV-: collateral ventilation absent; CV+: collateral ventilation present; BMI: body mass index; TLVR: target lobe volume reduction; FEV1: forced expiratory volume in 1 s; % pred: % predicted; DL,CO: diffusing capacity of the lung for carbon monoxide; RV: residual volume; TLC: total lung capacity; 6MWT: 6-min walking test; SGRQ: St. George’s Respiratory Questionnaire; LVRS: lung volume reduction surgery; BVR: bronchoscopic volume reduction. #: all patients (n=76); CV-all (n=49); CV-responders (n=34); CV+all (n=27); CV+nonresponders (n=3). ¶: all patients (n=58); CV-all (n=37); CV-responders (n=26); CV-nonresponders (n=11); CV+all (n=21); CV+nonresponders (n=18); CV+responders (n=3).